Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Akhurst

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapyMichael J Morris, Timothy Akhurst, Steven M Larson, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|May 13, 2016
Copper-64 trastuzumab PET imaging: a reproducibility studyJorge A Carrasquillo, Patrick G Morris, John L Humm, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2004
PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancerPat B Zanzonico, Ronald Finn, Keith S Pentlow, et al.
Endocrine-Related Cancer|May 27, 2025
Peptide receptor radionuclide therapy in malignant insulinomaDavid A Pattison, Grace Kong, Timothy Akhurst, et al.
Annals of Surgical Oncology|September 21, 2007
Positron emission tomography detection of distant metastatic or synchronous disease in patients with locally advanced rectal cancer receiving preoperative chemoradiationCaio S R Nahas, Timothy Akhurst, Henry Yeung, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion GlycolysisSteven M. Larson, Yusuf Erdi, Timothy Akhurst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 25, 2026
Prognostic Value of Restaging [<sup>18</sup>F]FDG PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [<sup>177</sup>Lu]Lu-PSMA-617 TherapyRaghava Kashyap, James P Buteau, Nathan Papa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomasSuzanne George, Priscilla Merriam, Robert G Maki, et al.
Theranostics|October 14, 2020
First clinical study of a pegylated diabody <sup>124</sup>I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancersAndrew M Scott, Timothy Akhurst, Fook-Thean Lee, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapyMichael J Morris, Timothy Akhurst, Steven M Larson, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|May 13, 2016
Copper-64 trastuzumab PET imaging: a reproducibility studyJorge A Carrasquillo, Patrick G Morris, John L Humm, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2004
PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancerPat B Zanzonico, Ronald Finn, Keith S Pentlow, et al.
Endocrine-Related Cancer|May 27, 2025
Peptide receptor radionuclide therapy in malignant insulinomaDavid A Pattison, Grace Kong, Timothy Akhurst, et al.
Annals of Surgical Oncology|September 21, 2007
Positron emission tomography detection of distant metastatic or synchronous disease in patients with locally advanced rectal cancer receiving preoperative chemoradiationCaio S R Nahas, Timothy Akhurst, Henry Yeung, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion GlycolysisSteven M. Larson, Yusuf Erdi, Timothy Akhurst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 25, 2026
Prognostic Value of Restaging [<sup>18</sup>F]FDG PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [<sup>177</sup>Lu]Lu-PSMA-617 TherapyRaghava Kashyap, James P Buteau, Nathan Papa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomasSuzanne George, Priscilla Merriam, Robert G Maki, et al.
Theranostics|October 14, 2020
First clinical study of a pegylated diabody <sup>124</sup>I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancersAndrew M Scott, Timothy Akhurst, Fook-Thean Lee, et al.
Pageof 4